231 related articles for article (PubMed ID: 18290776)
1. Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor-kappaB in chronic hepatitis C.
Hung CH; Lee CM; Kuo FY; Jiang SR; Hu TH; Chen CH; Wang JH; Lu SN; Eng HL; Changchien CS
Liver Int; 2008 Mar; 28(3):339-46. PubMed ID: 18290776
[TBL] [Abstract][Full Text] [Related]
2. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE
Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
Ribeiro PS; Cortez-Pinto H; Solá S; Castro RE; Ramalho RM; Baptista A; Moura MC; Camilo ME; Rodrigues CM
Am J Gastroenterol; 2004 Sep; 99(9):1708-17. PubMed ID: 15330907
[TBL] [Abstract][Full Text] [Related]
5. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
[TBL] [Abstract][Full Text] [Related]
6. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
[TBL] [Abstract][Full Text] [Related]
7. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression.
Boya P; Larrea E; Sola I; Majano PL; Jiménez C; Civeira MP; Prieto J
Hepatology; 2001 Nov; 34(5):1041-8. PubMed ID: 11679977
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ
Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.
Wedemeyer I; Bechmann LP; Odenthal M; Jochum C; Marquitan G; Drebber U; Gerken G; Gieseler RK; Dienes HP; Canbay A
J Hepatol; 2009 Jan; 50(1):140-9. PubMed ID: 19019483
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
[TBL] [Abstract][Full Text] [Related]
17. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
18. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
[TBL] [Abstract][Full Text] [Related]
19. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
Hézode C; Zafrani ES; Roudot-Thoraval F; Costentin C; Hessami A; Bouvier-Alias M; Medkour F; Pawlostky JM; Lotersztajn S; Mallat A
Gastroenterology; 2008 Feb; 134(2):432-9. PubMed ID: 18242211
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.
Hourigan LF; Macdonald GA; Purdie D; Whitehall VH; Shorthouse C; Clouston A; Powell EE
Hepatology; 1999 Apr; 29(4):1215-9. PubMed ID: 10094967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
